Xencor, Inc.
Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
Last updated:
Abstract:
The present invention is directed to a novel targeted heterodimeric Fc fusion proteins comprising an IL-15/IL-15R.alpha. Fc fusion protein and an antigen binding domain Fc fusion proteins. In some instances, the antigen binding domain binds to CD8, NKG2A, or NKG2D.
Status:
Grant
Type:
Utility
Filling date:
2 Jul 2018
Issue date:
10 Aug 2021